Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Bafna Pharma receives renewal certificate from UK MHRA

Bafna Pharmaceuticals has received renewal certificate, from UK Medicines and Healthcare products Regulatory Agency (MHRA).

The company’s facility, following the audit conducted has got renewal approval as per the guidelines of European Good Manufacturing Practices (EUGMP). Further, the board of directors of the company are scheduled to meet on May 28 to consider the unaudited financial results, for the quarter and the year ended March 31, 2018.

Read EquityPandit’s Technical Analysis of Nifty Pharma

Get Daily Prediction & Stocks Tips On Your Mobile